Certainly not an organised group posting. Looks like a few who observed the spring tightening with very little high/low variation. Big volume in the push up, so not all would be flippers.
https://www.pymnts.com/healthcare/2...tform-is-creating-the-pharmacy-of-the-future/
US competitors in this space have US$B market caps - McKesson, Cardinal, Cerner.
I'm not sure I'm an advocate for take over just yet or even at all.
PME started small and is now $14B on $76M half year revenue (H1FY24).
But they are raking in the profits. Looking forward to MDR growing their profit margins.
Ann: MDR Record FY24 Performance with Positive EBITDA and NPAT, page-29
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.005(1.27%) |
Mkt cap ! $212.2M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 39.5¢ | 38.5¢ | $17.79K | 45.59K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 39554 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 30150 | 3 |
View Market Depth
| Last trade - 14.02pm 18/09/2024 (20 minute delay) ? |
| MDR (ASX) Chart |